2009 Fiscal Year Final Research Report
Identification of Perpetuating Factor for Liver Tissue Inflammation in Hepatic Carcinogenesis
| Project/Area Number |
19591595
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Kagoshima University |
|---|
Principal Investigator |
UENO Shinichi Kagoshima University, 大学院・医歯学総合研究科, 准教授 (40322317)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
AIKOU Takashi 鹿児島大学, 大学院・医歯学総合研究科, 教授 (60117471)
ABEYAMA Kazuhiro 鹿児島大学, 大学院・医歯学総合研究科, 客員研究員 (30284897)
MARUYAMA Ikurou 鹿児島大学, 大学院・医歯学総合研究科, 教授 (20082282)
SAKODA Masahiko 鹿児島大学, 医学部・歯学部附属病院, 医員 (40418851)
|
|---|
| Project Period (FY) |
2007 – 2009
|
| Keywords | RAGE / HMGB1 / HCC / Esophageal ca / Carcinogenseis |
|---|
| Research Abstract |
1) The expression of RAGE mRNA was lower in normal liver than in hepatitis and highest in HCC. Furthermore, in HCC, it was high in well- and moderately differentiated tumors but declined as tumors dedifferentiated to poorly differentiated HCC. Furthermore, HCC lines resistant to hypoxia were found to have higher levels of RAGE expression, and RAGE transfectant also showed significantly prolonged survival under hypoxia. Our results suggest that HCC during the early stage of tumorigenesis with less blood supply may acquire resistance to stringent hypoxic milieu by hypoxia-induced RAGE expression. 2) Loss of RAGE expression may play an important role in the progression of esophageal squamous cell carcinoma. Evaluation of the expression of RAGE could be useful for determining the tumor properties, including those associated with prognosis, in patients with esophageal squamous cell carcinoma. 3) The presence of RAGE might suppress HIF-1a protein expression, which in turn might induce an anti-apoptosis effect in RAGE-transfected Cos7 cells. Moreover, the p53 suppression induced by HIF-1a may lead to malignant potential in RAGE-transfected Cos7 cells.
|
